Treg cells as potential cellular targets for functionalized nanoparticles in cancer therapy
出版年份 2016 全文链接
标题
Treg cells as potential cellular targets for functionalized nanoparticles in cancer therapy
作者
关键词
-
出版物
Nanomedicine
Volume 11, Issue 20, Pages 2699-2709
出版商
Future Medicine Ltd
发表日期
2016-09-21
DOI
10.2217/nnm-2016-0197
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Memory of Inflammation in Regulatory T Cells
- (2016) Joris van der Veeken et al. CELL
- Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation
- (2016) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Efficient nucleic acid delivery to murine regulatory T cells by gold nanoparticle conjugates
- (2016) Lisa Gamrad et al. Scientific Reports
- Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses
- (2015) Nikhil S. Joshi et al. IMMUNITY
- Directed Interactions of Block Copolypept(o)ides with Mannose-binding Receptors: PeptoMicelles Targeted to Cells of the Innate Immune System
- (2015) Philipp Heller et al. MACROMOLECULAR BIOSCIENCE
- Nanoparticles and antigen-specific T-cell therapeutics: a comprehensive study on uptake and release
- (2015) Oliver Zupke et al. Nanomedicine
- In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel Particles
- (2015) Leonard Kaps et al. Advanced Healthcare Materials
- Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
- (2014) Zhenghong Xu et al. ACS Nano
- Release from Regulatory T Cell-Mediated Suppression during the Onset of Tissue-Specific Autoimmunity Is Associated with Elevated IL-21
- (2014) L. E. Clough et al. JOURNAL OF IMMUNOLOGY
- New Techniques to Assess In Vitro Release of siRNA from Nanoscale Polyplexes
- (2014) Bettina Krieg et al. PHARMACEUTICAL RESEARCH
- Investigating the optimal size of anticancer nanomedicine
- (2014) L. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CpG-Loaded Multifunctional Cationic Nanohydrogel Particles as Self-Adjuvanting Glycopeptide Antitumor Vaccines
- (2014) Sebastian Hartmann et al. Advanced Healthcare Materials
- Polypeptoid-block-polypeptide Copolymers: Synthesis, Characterization, and Application of Amphiphilic Block Copolypept(o)ides in Drug Formulations and Miniemulsion Techniques
- (2013) Alexander Birke et al. BIOMACROMOLECULES
- Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response
- (2013) Susan N. Thomas et al. BIOMATERIALS
- Interferon- Suppresses cAMP to Disarm Human Regulatory T Cells
- (2013) N. Bacher et al. CANCER RESEARCH
- Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
- (2013) B. Kwong et al. CANCER RESEARCH
- FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells
- (2013) Dewan Md Sakib Hossain et al. IMMUNITY
- An Inherently Bifunctional Subset of Foxp3+ T Helper Cells Is Controlled by the Transcription Factor Eos
- (2013) Madhav D. Sharma et al. IMMUNITY
- Synthesis of Nanostructured and Biofunctionalized Water-in-Oil Droplets as Tools for Homing T Cells
- (2013) Ilia Platzman et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- 'Nurr'ishing Treg cells: Nr4a transcription factors control Foxp3 expression
- (2013) Hozefa S Bandukwala et al. NATURE IMMUNOLOGY
- Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis
- (2013) Bettina Trinschek et al. PLoS One
- Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma
- (2013) Wiebke Hansen OncoImmunology
- TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis
- (2012) Zhijuan Diao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Engineering DNA Nanoparticles as Immunomodulatory Reagents that Activate Regulatory T Cells
- (2012) L. Huang et al. JOURNAL OF IMMUNOLOGY
- Interleukin-6 Inhibits Regulatory T Cells and Improves the Proliferation and Cytotoxic Activity of Cytokine-induced Killer Cells
- (2012) Guohe Lin et al. JOURNAL OF IMMUNOTHERAPY
- Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-γ, IL-2 and IL-2R
- (2012) Jingxian Zhao et al. PLoS One
- Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery
- (2012) J. Predina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple treg suppressive modules and their adaptability
- (2012) James B. Wing et al. Frontiers in Immunology
- Interleukin-12 Converts Foxp3+ Regulatory T Cells to Interferon–γ-Producing Foxp3+ T Cells That Inhibit Colitis
- (2011) Ting Feng et al. GASTROENTEROLOGY
- A Requisite Role for Induced Regulatory T Cells in Tolerance Based on Expanding Antigen Receptor Diversity
- (2011) Dipica Haribhai et al. IMMUNITY
- Regulatory T cells and Foxp3
- (2011) Alexander Y. Rudensky IMMUNOLOGICAL REVIEWS
- Repression of Cyclic Adenosine Monophosphate Upregulation Disarms and Expands Human Regulatory T Cells
- (2011) M. Klein et al. JOURNAL OF IMMUNOLOGY
- A Role for IL-27 in Limiting T Regulatory Cell Populations
- (2011) E. D. Tait Wojno et al. JOURNAL OF IMMUNOLOGY
- Effective Melanoma Immunotherapy with Interleukin-2 Delivered by a Novel Polymeric Nanoparticle
- (2011) H. Yao et al. MOLECULAR CANCER THERAPEUTICS
- Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation
- (2011) Marc Beyer et al. NATURE IMMUNOLOGY
- The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells
- (2011) Erika Cretney et al. NATURE IMMUNOLOGY
- Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1)
- (2011) M. Vaeth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response
- (2011) Lei Sun et al. TRANSPLANT IMMUNOLOGY
- Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
- (2010) K. Klages et al. CANCER RESEARCH
- Cyclic adenosine monophosphate and IL-10 coordinately contribute to nTreg cell-mediated suppression of dendritic cell activation
- (2010) Melanie Fassbender et al. CELLULAR IMMUNOLOGY
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination
- (2010) Anita Correll et al. EXPERIMENTAL DERMATOLOGY
- Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients
- (2010) Ingrid M.E. Desar et al. INTERNATIONAL JOURNAL OF CANCER
- The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles
- (2010) Helen Lee et al. MOLECULAR PHARMACEUTICS
- Modulation of CD4+ T Lymphocyte Lineage Outcomes with Targeted, Nanoparticle-Mediated Cytokine Delivery
- (2010) Jason Park et al. MOLECULAR PHARMACEUTICS
- Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease
- (2009) X. Chen et al. BLOOD
- T-Regulatory Cells Shift from a Protective Anti-Inflammatory to a Cancer-Promoting Proinflammatory Phenotype in Polyposis
- (2009) Elias Gounaris et al. CANCER RESEARCH
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of cAMP Degradation Improves Regulatory T Cell-Mediated Suppression
- (2009) T. Bopp et al. JOURNAL OF IMMUNOLOGY
- Nonfunctional Regulatory T Cells and Defective Control of Th2 Cytokine Production in Natural Scurfy Mutant Mice
- (2009) K. Lahl et al. JOURNAL OF IMMUNOLOGY
- Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
- (2009) Steven D. Perrault et al. NANO LETTERS
- Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses
- (2009) Ana Lucia Dominguez et al. VACCINE
- Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis
- (2008) Ana Izcue et al. IMMUNITY
- Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
- (2008) Yuri P. Rubtsov et al. IMMUNITY
- Immunomodulatory and anticancer effects of intra-tumoral co-delivery of synthetic lipid A adjuvant and STAT3 inhibitor, JSI-124
- (2008) Ommoleila Molavi et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin
- (2008) Minghuang Hong et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
- (2008) Paolo Decuzzi et al. PHARMACEUTICAL RESEARCH
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now